Myriad Genetics, Inc. 8-K Report: Key Insights from February 24, 2025 Filing

Based on the provided XML section of the financial report, here are the key information and insights extracted:

Company Information:

Name: Myriad Genetics, Inc.
CIK: 0000899923
State of Incorporation: Delaware (DE)
IRS Employer Identification Number (EIN): 87-0494517
Address: 322 North 2200 West, Salt Lake City, UT 84116
Phone Number: 801-584-3600
Stock Symbol: MYGN
Exchange: NASDAQ

Filing Information:

Filing Type: 8-K (Current Report)
Filing Date: February 24, 2025
Period Covered: February 24, 2025 (the same date as the filing)

Securities Information:

Type of Security: Common Stock
Par Value: $0.01

Context Information:

XML Schema Reference: The report references an XSD schema file (mygn-20250224.xsd), indicating that it adheres to a specific structure for XBRL filings.

Insights:

The filing is a Form 8-K, which typically reports material events or corporate changes that could be of importance to shareholders and investors.
The filing date and the period covered are the same, which suggests that this report may be addressing a specific event that occurred on that date.
The company is actively listed on NASDAQ under the ticker symbol MYGN, indicating its status as a publicly traded company.
The details about the company and its securities suggest a focus on transparency and compliance with SEC regulations.

Overall, this section provides a snapshot of Myriad Genetics, Inc. as of February 24, 2025, underlining its compliance with SEC filing requirements and its operational status in the market.